DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. 1989

Y H Hsiang, and L F Liu, and M E Wall, and M C Wani, and A W Nicholas, and G Manikumar, and S Kirschenbaum, and R Silber, and M Potmesil
Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

20(S)-Camptothecin, the 20(S)-camptothecin sodium salt, and 12 analogues with substituents on the A ring differ widely in their effectiveness in the treatment of murine L1210 lymphoblastic leukemia in vivo. The drugs were screened in the following systems: System 1, the cleavage of DNA in the presence of purified topoisomerase I; System 2, drug-induced trapping of topoisomerase I in a covalent complex with DNA; and System 3, the induction of protein-associated DNA breaks in drug-treated L1210 leukemia cells. 9-Amino-20(S), 10-amino-20(RS), and 10,11-methylenedioxy-20(RS), drugs effective against murine L1210 leukemia in vivo, stabilize topoisomerase I-DNA cleavable complexes in a purified system and in cultured L1210 cells. Other analogues, inactive against L1210 leukemia in vivo, were totally ineffective in topoisomerase I-directed screens. The rest of the analogues were intermediate in terms of their antitumor and topoisomerase I-directed activities. The study shows that the drug-induced accumulation of enzyme-DNA cleavable complexes is directly proportional to drug cytotoxicity and antitumor activity.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D004270 DNA, Circular Any of the covalently closed DNA molecules found in bacteria, many viruses, mitochondria, plastids, and plasmids. Small, polydisperse circular DNA's have also been observed in a number of eukaryotic organisms and are suggested to have homology with chromosomal DNA and the capacity to be inserted into, and excised from, chromosomal DNA. It is a fragment of DNA formed by a process of looping out and deletion, containing a constant region of the mu heavy chain and the 3'-part of the mu switch region. Circular DNA is a normal product of rearrangement among gene segments encoding the variable regions of immunoglobulin light and heavy chains, as well as the T-cell receptor. (Riger et al., Glossary of Genetics, 5th ed & Segen, Dictionary of Modern Medicine, 1992) Circular DNA,Circular DNAs,DNAs, Circular
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

Y H Hsiang, and L F Liu, and M E Wall, and M C Wani, and A W Nicholas, and G Manikumar, and S Kirschenbaum, and R Silber, and M Potmesil
June 2009, Protein science : a publication of the Protein Society,
Y H Hsiang, and L F Liu, and M E Wall, and M C Wani, and A W Nicholas, and G Manikumar, and S Kirschenbaum, and R Silber, and M Potmesil
July 2003, Nucleic acids research,
Y H Hsiang, and L F Liu, and M E Wall, and M C Wani, and A W Nicholas, and G Manikumar, and S Kirschenbaum, and R Silber, and M Potmesil
July 1988, Journal of molecular biology,
Y H Hsiang, and L F Liu, and M E Wall, and M C Wani, and A W Nicholas, and G Manikumar, and S Kirschenbaum, and R Silber, and M Potmesil
December 1992, Journal of molecular biology,
Y H Hsiang, and L F Liu, and M E Wall, and M C Wani, and A W Nicholas, and G Manikumar, and S Kirschenbaum, and R Silber, and M Potmesil
December 1996, Annals of the New York Academy of Sciences,
Y H Hsiang, and L F Liu, and M E Wall, and M C Wani, and A W Nicholas, and G Manikumar, and S Kirschenbaum, and R Silber, and M Potmesil
July 2002, European journal of biochemistry,
Y H Hsiang, and L F Liu, and M E Wall, and M C Wani, and A W Nicholas, and G Manikumar, and S Kirschenbaum, and R Silber, and M Potmesil
December 2007, ChemMedChem,
Y H Hsiang, and L F Liu, and M E Wall, and M C Wani, and A W Nicholas, and G Manikumar, and S Kirschenbaum, and R Silber, and M Potmesil
January 2001, Angewandte Chemie (International ed. in English),
Y H Hsiang, and L F Liu, and M E Wall, and M C Wani, and A W Nicholas, and G Manikumar, and S Kirschenbaum, and R Silber, and M Potmesil
January 1989, Molekuliarnaia biologiia,
Y H Hsiang, and L F Liu, and M E Wall, and M C Wani, and A W Nicholas, and G Manikumar, and S Kirschenbaum, and R Silber, and M Potmesil
July 1985, Biochemical pharmacology,
Copied contents to your clipboard!